EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluation of phenotypic and genotypic methods for detecting KPC variants

Yasmine Benhadid-Brahmi iD, Claire Amaris Hobson, Lydia Abdelmoumene, Ella Jaouen, Mélanie Magnan, Maud Gits-Muselli, Mathilde Lescat, Olivier Tenaillon, Stéphane Bonacorsi, André Birgy iD

Antimicrobial Agents and Chemotherapy · 07.05.2025 · 69 (5)

DOI: 10.1128/aac.00082-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, erschienen am 07.05.2025. Verfasst von Yasmine Benhadid-Brahmi und 9 weiteren Autor:innen. Beteiligte Einrichtung: IAME, UMR 1137, INSERM, Université Paris Cité, Paris, Île-de-France, France. Hauptthemen laut MEDLINE: beta-Lactamases, Klebsiella pneumoniae, Anti-Bacterial Agents, Bacterial Proteins. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Institut National de la Santé et de la Recherche Médicale.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Klebsiella pneumoniae carbapenemases (KPCs) have spread and diversified extensively. To date, 242 clinical variants have been identified and harbor different hydrolytic capacities, thereby interfering with rapid diagnostic tests. The accurate detection of KPC variants is crucial to guide treatment and control measures in healthcare settings. We constructed KPC variants to assess the mutational impact on detection capacities of resistance-based tests. KPC variants ( n = 45) were characterized phenotypically and used to measure the detection sensitivity of KPC detection methods (two lateral flow immunoassays [LFIAs], three hydrolysis tests, three selective culture media, and two PCR-based tests). We identified four antibiotic susceptibility patterns: “KPC-like” (23/45; 51%), “extended-spectrum beta-lactamase-like” (6/45; 13%), “ceftazidimase” (9/45; 20%), and outlier variants with “mixed-profiles” (5/45; 11%). These phenotypes had different impacts on the detection capabilities of hydrolysis tests (0%–100%), LFIA (44%–100%), and selective culture media (0%–100%), highlighting a risk of misdiagnosis for some KPC variants. All variants were detected with PCR-based tests. To detect the maximum of KPC variants, fecal carriage screening requires a combination of selective media targeting resistance to carbapenems, third-generation cephalosporins, and ceftazidime-avibactam. From antibiotic susceptibility testing, resistance to ceftazidime ± avibactam and specific phenotypic profiles should be used as warnings to track the presence of KPC variants. We recommend LFIA as a first-line test, owing to its high sensitivity in detecting KPC variants. Nevertheless, using a combination of tests may remain wise in some situations. The spread of KPC variants remains a significant concern, particularly as reversion to ancestral phenotype could restore carbapenem resistance and lead to therapeutic failure

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

beta-LactamasesKlebsiella pneumoniaeAnti-Bacterial AgentsBacterial ProteinsMicrobial Sensitivity TestsPhenotypeHumansGenotype

Stichwörter der Autor:innen

KPC beta-lactamaseLFIA testsclinical KPC variantsdetection testshydrolysis-based tests

Substanzen

beta-LactamasesAnti-Bacterial AgentscarbapenemaseBacterial Proteins

Autor:innen und Institutionen

  • IAME, UMR 1137, INSERM, Université Paris Cité, Paris, Île-de-France, France.
  • Service de Microbiologie, Hôpital Robert-Debré, AP-HP, Paris, France.
  • Service de Maladies Infectieuses et Tropicales, Hôpital Bichat, AP-HP, Paris, France.
  • Bacteriology Unit, CNR le Charbon, Microbiology and Infectious Diseases Department, Institut de Recherche Biomédicale des Armées, Brétigny-sur-Orge, Île-de-France, France.

ORCID-Profile: Yasmine Benhadid-Brahmi, André Birgy

Förderung

  • Institut National de la Santé et de la Recherche Médicale

Zitieren

APA

Benhadid-Brahmi, Y., Amaris Hobson, C., Abdelmoumene, L., Jaouen, E., Magnan, M., Gits-Muselli, M., Lescat, M., Tenaillon, O., Bonacorsi, S., & Birgy, A. (2025). Evaluation of phenotypic and genotypic methods for detecting KPC variants. Antimicrobial Agents and Chemotherapy, 69(5). https://doi.org/10.1128/aac.00082-25

Vancouver

Benhadid-Brahmi Y, Amaris Hobson C, Abdelmoumene L, Jaouen E, Magnan M, Gits-Muselli M, et al. Evaluation of phenotypic and genotypic methods for detecting KPC variants. Antimicrobial Agents and Chemotherapy. 2025;69(5). doi:10.1128/aac.00082-25

BibTeX
@article{BenhadidBrahmi2025,
  author = {Benhadid-Brahmi, Yasmine and Amaris Hobson, Claire and Abdelmoumene, Lydia and Jaouen, Ella and Magnan, Mélanie and Gits-Muselli, Maud and Lescat, Mathilde and Tenaillon, Olivier and Bonacorsi, Stéphane and Birgy, André},
  title = {Evaluation of phenotypic and genotypic methods for detecting KPC variants},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2025},
  volume = {69},
  number = {5},
  doi = {10.1128/aac.00082-25}
}
Kostenlos starten →